top of page
Search

Biosynth Offers Novel Human Hybrid IgM Monoclonal Antibodies to Replace Natural Disease State Plasma
Dublin, Ireland, 31st August 2023 – Biosynth Ltd, is delighted to offer the following innovative range of novel Human Hybrid IgM...
Catie Barrett
Aug 31, 20232 min read
151 views
1 comment


Rebrand of Aalto Bio Reagents and Fitzgerald Industries International to Biosynth
We have collected some of the frequently asked questions related to our rebrand on August 1st, 2023, to ensure a smooth transition. For...
Claire Duffy
Aug 1, 20232 min read
204 views
0 comments


Aalto Bio Reagents Launches Antibody to Cholera Toxin B Amidst Cholera Outbreak and Vaccine Shortage
Dublin, Ireland – 30th May 2023 - Aalto Bio Reagents, has recently launched their new Mouse Monoclonal Antibody (MAb) to Cholera Toxin B...
Catie Barrett
Jun 16, 20232 min read
162 views
0 comments

Aalto Bio Reagents Launches New Monkeypox Virus B21R-BSA Conjugate Peptides for Diagnostic Testing
Dublin, Ireland – 10th October 2022 - Aalto Bio Reagents Ltd., a leading global supplier of critical raw materials to the in-vitro...
Rachel O'Reilly
Oct 10, 20222 min read
203 views
0 comments
bottom of page